2018

Use of Oncolytic Adenovirus Expressing Interferon (IFN) Alpha as a Tool to Improve IFN-Based Chemoradiation Regimen to Treat Pancreatic Cancer

Visit USCO

Text Registration

Use of Oncolytic Adenovirus Expressing Interferon (IFN) Alpha as a Tool to Improve IFN-Based Chemoradiation Regimen to Treat Pancreatic Cancer

Status

Published

on 22 May 2018

Year of Creation

2018

Amanda Oliveira Salzwedel

Registration Number

TX0008612660

on 22 May 2018

The U.S. Copyright record (Registration Number: TX0008612660) dated 22 May 2018, pertains to an electronic file (eService) titled "Use of Oncolytic Adenovirus Expressing Interferon (IFN) Alpha as a Tool to Improve IFN-Based Chemoradiation Regimen to Treat Pancreatic Cancer" created in 2018. The copyright holder is Amanda Oliveira Salzwedel, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Amanda Oliveira Salzwedel.

Amanda Oliveira Salzwedel

Application Details

Registration Number

TX0008612660

Registration Date

5/22/2018

Year of Creation

2018

Agency Marc Code

DLC-CO

Record Status

New

Physical Description

Electronic file (eService)

First Publication Nation

United States

Personal Authors

Amanda Oliveira Salzwedel

Notes

Rights Note: Mark Dill, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements

Application Title Statement: Use of Oncolytic Adenovirus Expressing Interferon (IFN) Alpha as a Tool to Improve IFN-Based Chemoradiation Regimen to Treat Pancreatic Cancer

Author Statement: Amanda Oliveira Salzwedel Citizenship: not known Authorship: text

Notes

Rights Note: Mark Dill, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements

Application Title Statement: Use of Oncolytic Adenovirus Expressing Interferon (IFN) Alpha as a Tool to Improve IFN-Based Chemoradiation Regimen to Treat Pancreatic Cancer

Author Statement: Amanda Oliveira Salzwedel Citizenship: not known Authorship: text

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.